The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials
Abstract
Context Safe and effective strategies to curb rising obesity prevalence rates are urgently needed and medications may play a more prominent role in future therapeutic regimens. Objective To review systematically the long-term efficacy and safety of approved antiobesity medications. Data sources MEDLINE, EMBASE, the Cochrane Controlled Trials Register, Current Science Meta-register of Controlled Trials, and reference lists of original studies and reviews were searched. Drug manufacturers and two obesity experts were contacted. No language restrictions were imposed. Study selection Double-blind, randomized controlled studies of approved antiobesity medications with follow-up periods of 1 y or greater were eligible for inclusion. Data extraction Two reviewers independently assessed all potentially relevant studies for inclusion and methodological quality using standardized abstraction forms. Results A total of 11orlistat (n=6021) and three sibutramine (n=929) studies met inclusion criteria. Attrition rates averaged 33% in orlistat studies and 48% in sibutramine studies. A random effects model was used for meta-analysis. Compared to placebo, orlistat-treated patients displayed a 2.7 kg (95% CI: 2.3-3.1 kg) or 2.9% (95% CI: 2.3-3.4%) greater reduction in weight and patients on sibutramine displayed a 4.3 kg (95% CI: 3.6-4.9 kg) or 4.6% (95% CI: 3.8-5.4%) greater weight reduction after 1 y of follow-up. The number of patients achieving 10% or greater weight loss was 12% (95% CI: 8-…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A pancreatic lipase inhibitor, orlistat blocks dietary fat absorption, resulting in ~3–5% weight loss.”
From Obesity: Clinical Impact, Pathophysiology, Complications, and Modern Innovations in Therapeutic Strategies (2025) · cites this paper as [57]
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
(1998) · PsycEXTRA Dataset · doi:10.1037/e565682010-001 · Cited by 9,472
Prevalence and trends in obesity among US adults, 1999–2000
Flegal, K. M. (2002) · JAMA · doi:10.1001/jama.288.14.1723 · Cited by 6,190
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826
Kopelman, P. G. (2000) · Nature · doi:10.1038/35007508 · Cited by 4,795
Prevalence and Trends in Overweight Among US Children and Adolescents, 1999-2000
Ogden, C. L. (2002) · JAMA · doi:10.1001/jama.288.14.1728 · Cited by 4,060
Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults
Calle, E. E., Thun, M. J., Petrelli, J. M., Rodriguez, C., & Heath, C. W. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910073411501 · Cited by 3,643
Cited by
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.004 · Cited by 4,058
Haslam, D. W., & James, W. P. T. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67483-1 · Cited by 3,757
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437739.71477.ee · Cited by 2,735
“The remaining 28 publications were rated good or fair quality and included in the evidence base that was used to formulate the ESs and recommendations (12-39).”
BackgroundLegro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919
Pi-Sunyer, F. X., Aronne, L. J., Heshmati, H. M., Devin, J., Rosenstock, J., & RIO-North America Study Group, F. T. (2006) · JAMA · doi:10.1001/jama.295.7.761 · Cited by 1,218
Prepared by: British Cardiac Society, B. H. S. (2005) · Heart · doi:10.1136/hrt.2005.079988 · Cited by 1,216
Multicenter, placebo-controlled trial of lorcaserin for weight management.
Smith, S. R., Weissman, N. J., Anderson, C. M., Sanchez, M., Chuang, E., Stubbe, S., Bays, H., & Shanahan, W. R. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909809 · Cited by 911
Long-term Drug Treatment for Obesity: A Systematic and Clinical Review
Yanovski, S. Z., & Yanovski, J. A. (2014) · JAMA · doi:10.1001/jama.2013.281361 · Cited by 876
Borenstein, M., & Higgins, J. P. T. (2013) · Prevention Science · doi:10.1007/s11121-013-0377-7 · Cited by 767
Drug treatments for obesity: orlistat, sibutramine, and rimonabant
Padwal, R. S., & Majumdar, S. R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60033-6 · Cited by 753
Self-citationScheen, A. J., Finer, N., Hollander, P., Jensen, M. D., & Van Gaal, L. F. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69571-8 · Cited by 736
Douketis, J. D., Macie, C., Thabane, L., & Williamson, D. F. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802982 · Cited by 665
Salas-Salvadó, J., Rubio, M. A., Barbany, M., & Moreno, B. (2007) · Medicina Clínica · doi:10.1016/s0025-7753(07)72531-9 · Cited by 571
Role of neuropeptides in appetite regulation and obesity – A review
Arora, S., & Anubhuti (2006) · Neuropeptides · doi:10.1016/j.npep.2006.07.001 · Cited by 455
Orlistat-Associated Adverse Effects and Drug Interactions: A Critical Review
Filippatos, T. D., Derdemezis, C. S., Gazi, I. F., Nakou, E. S., Mikhailidis, D. P., & Elisaf, M. S. (2008) · Drug Safety · doi:10.2165/00002018-200831010-00005 · Cited by 434
Grazing and Loss of Control Related to Eating: Two High‐risk Factors Following Bariatric Surgery
Colles, S. L., Dixon, J. B., & O'Brien, P. E. (2008) · Obesity · doi:10.1038/oby.2007.101 · Cited by 420
Jorde, R., Sneve, M., Figenschau, Y., Svartberg, J., & Waterloo, K. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.02008.x · Cited by 433
Adipose Tissue and Atherosclerosis: Exploring the Connection
Fantuzzi, G., & Mazzone, T. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.106.131755 · Cited by 384
Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study
Gray, R. H., Li, X., Kigozi, G., Serwadda, D., Brahmbhatt, H., Wabwire-Mangen, F., Nalugoda, F., Kiddugavu, M., Sewankambo, N., Quinn, T. C., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67481-8 · Cited by 358
Members, E. P., Jensen, M. D., Ryan, D. H., Donato, K. A., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Hu, F. B., Hubbard, V. S., Jakicic, J. M., et al. (2014) · Obesity · doi:10.1002/oby.20821 · Cited by 333
Lipid metabolic enzymes: emerging drug targets for the treatment of obesity
Shi, Y., & Burn, P. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1469 · Cited by 333
Colquitt, J. L., Clegg, A. J., Loveman, E., Royle, P., & Sidhu, M. K. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003641.pub2 · Cited by 308
Serotonergic Drugs: Effects on Appetite Expression and Use for the Treatment??of Obesity
Halford, J. C. G., Harrold, J. A., Boyland, E. J., Lawton, C. L., & Blundell, J. E. (2007) · Drugs · doi:10.2165/00003495-200767010-00004 · Cited by 307
Obesity and hypertension: two epidemics or one?
Davy, K. P., & Hall, J. E. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00707.2003 · Cited by 280
Gut hormones in the control of appetite
Murphy, K. G., & Bloom, S. R. (2004) · Experimental Physiology · doi:10.1113/expphysiol.2004.027789 · Cited by 250
Randomized Clinical Trials of Weight Loss Maintenance: A Review
Turk, M. W., Yang, K., Hravnak, M., Sereika, S. M., Ewing, L. J., & Burke, L. E. (2009) · Journal of Cardiovascular Nursing · doi:10.1097/01.jcn.0000317471.58048.32 · Cited by 258
Expert panel report: Guidelines (2013) for the management of overweight and obesity in adults
(2014) · Obesity · doi:10.1002/oby.20660 · Cited by 257
Pharmacotherapies for Obesity: Past, Current, and Future Therapies
Ioannides-Demos, L. L., Piccenna, L., & McNeil, J. J. (2011) · Journal of Obesity · doi:10.1155/2011/179674 · Cited by 243
Shi, Y., & Cheng, D. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90949.2008 · Cited by 232
Valerio, G., Maffeis, C., Saggese, G., Ambruzzi, M. A., Balsamo, A., Bellone, S., Bergamini, M., Bernasconi, S., Bona, G., Calcaterra, V., et al. (2018) · Italian Journal of Pediatrics · doi:10.1186/s13052-018-0525-6 · Cited by 225
Skeletal muscle thermogenesis and its role in whole body energy metabolism
Periasamy, M., Herrera, J. L., & Reis, F. C. G. (2017) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2017.41.5.327 · Cited by 230
Bariatric surgery: Mechanisms, indications and outcomes
O'Brien, P. E. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06391.x · Cited by 214
Effect of Obesity on High‐density Lipoprotein Metabolism
Rashid, S., & Genest, J. (2007) · Obesity · doi:10.1038/oby.2007.342 · Cited by 212
Erondu, N., Gantz, I., Musser, B., Suryawanshi, S., Mallick, M., Addy, C., Cote, J., Bray, G., Fujioka, K., Bays, H., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.08.002 · Cited by 183
Ioannides-Demos, L. L., Proietto, J., & McNeil, J. J. (2005) · Drugs · doi:10.2165/00003495-200565100-00006 · Cited by 165
Saffron: A Natural Potent Antioxidant as a Promising Anti-Obesity Drug
Mashmoul, M., Azlan, A., Khaza'ai, H., Yusof, B., & Noor, S. (2013) · Antioxidants · doi:10.3390/antiox2040293 · Cited by 160
Calorie restriction mimetics: Can you have your cake and eat it, too?
Ingram, D. K., & Roth, G. S. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2014.11.005 · Cited by 161
Medicinal Plants and Their Inhibitory Activities against Pancreatic Lipase: A Review
Seyedan, A., Alshawsh, M. A., Alshagga, M. A., Koosha, S., & Mohamed, Z. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/973143 · Cited by 182
Overviews of Pathogen Emergence: Which Pathogens Emerge, When and Why?
Cleaveland, S., Haydon, D. T., & Taylor, L. H. (2007) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-70962-6_5 · Cited by 195
Safety of Drug Therapies Used for Weight Loss and Treatment of Obesity
Ioannides‐Demos, L. L., Proietto, J., Tonkin, A. M., & McNeil, J. J. (2006) · Drug Safety · doi:10.2165/00002018-200629040-00001 · Cited by 166
Pharmacological Therapies for Obesity
Kaplan, L. M. (2005) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2004.12.002 · Cited by 149
Food Ingredients as Anti-Obesity Agents: A Review
Trigueros, L., Peña, S., Ugidos, A. V., Sayas‐Barberá, E., Pérez‐Álvarez, J. Á., & Sendra, E. (2013) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2011.574215 · Cited by 160
Long-Term Outcomes after Gastric Bypass
White, S., Brooks, E., Jurikova, L., & Stubbs, R. S. (2005) · Obesity Surgery · doi:10.1381/0960892053268282 · Cited by 141
The challenge for global health systems in preventing and managing obesity
Wolfenden, L., Ezzati, M., Larijani, B. A., & Dietz, W. H. (2019) · Obesity Reviews · doi:10.1111/obr.12872 · Cited by 151
Risks and benefits of bariatric surgery: current evidence.
Brethauer, S. A., Chand, B., & Schauer, P. R. (2006) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.73.11.993 · Cited by 163
Powell, L. H., Calvin, J. E., & Calvin, J. E. (2007) · American Psychologist · doi:10.1037/0003-066x.62.3.234 · Cited by 148
The effects of a new soluble dietary fiber on weight gain and selected blood parameters in rats
Artiss, J. D., Brogan, K. E., Brucal, M., Moghaddam, M., & Jen, K.-L. C. (2006) · Metabolism · doi:10.1016/j.metabol.2005.08.012 · Cited by 151
Diabesity: therapeutic options
Colagiuri, S. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01182.x · Cited by 136
Busetto, L., Dixon, J., De Luca, M., Shikora, S., Pories, W., & Angrisani, L. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1214-1 · Cited by 118
Long-term persistence with orlistat and sibutramine in a population-based cohort
Padwal, R. S., Kezouh, A., Levine, M. N., & Etminan, M. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803631 · Cited by 125
Self-citationNieuwenhuis-Ruifrok, A. E., Kuchenbecker, W. K. H., Hoek, A., Middleton, P., & Norman, R. J. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn043 · Cited by 110
Bray, G. A. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0680124 · Cited by 128
Treating obesity in individuals and populations
Jain, A. (2005) · BMJ · doi:10.1136/bmj.331.7529.1387 · Cited by 120
ASMBS updated position statement on bariatric surgery in class I obesity (BMI 30–35 kg/m2)
Aminian, A., Chang, J., Brethauer, S. A., & Kim, J. J. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.05.025 · Cited by 106
The Role of Obesity in the Development of Polycystic Ovary Syndrome
Motta, A. B. (2012) · Current Pharmaceutical Design · doi:10.2174/13816128112092482 · Cited by 124
Cercato, C., Roizenblatt, V. A., Leança, C. C., Segal, A., Lopes Filho, A. P., Mancini, M. C., & Halpern, A. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.124 · Cited by 100
Alba, M., Yee, J., Frustaci, M. E., Samtani, M. N., & Fleck, P. (2021) · Clinical Obesity · doi:10.1111/cob.12432 · Cited by 100
Nonalcoholic fatty liver disease: from pathogenesis to patient care
Perlemuter, G., Bigorgne, A., Cassard, A., & Naveau, S. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0505 · Cited by 108
Evaluation and management of non-alcoholic steatohepatitis
Ramesh, S., & Sanyal, A. J. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.11.022 · Cited by 105
Pharmacotherapy of Childhood Obesity
Freemark, M. (2007) · Diabetes Care · doi:10.2337/dc06-1569 · Cited by 98
A review of the metabolic effects of sibutramine
Filippatos, T. D., Kiortsis, D. N., Liberopoulos, E. N., Mikhailidis, D. P., & Elisaf, M. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x38132 · Cited by 90
Pharmacological Approaches to Weight Reduction: Therapeutic Targets
Körner, J., & Aronne, L. J. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0341 · Cited by 90
Orlistat: current status in clinical therapeutics
McClendon, K. S., Riche, D. M., & Uwaifo, G. I. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330903321485 · Cited by 93
Osei‐Assibey, G., Kyrou, I., Adi, Y., Kumar, S., & Matyka, K. (2010) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00695.x · Cited by 81
Present and Future: Pharmacologic Treatment of Obesity
Glandt, M., & Raz, I. (2011) · Journal of Obesity · doi:10.1155/2011/636181 · Cited by 95
Inhibitory Properties of Phenolic Compounds Against Enzymes Linked with Human Diseases
Gonçalves, S., & Romano, A. (2017) · InTech eBooks · doi:10.5772/66844 · Cited by 81
Dong, Z., Xu, X., Wang, C., Cartledge, S. H., Maddison, R., & Islam, S. M. S. (2020) · Obesity Medicine · doi:10.1016/j.obmed.2020.100185 · Cited by 88
Gut Hormones and Energy Balance, The Future for Obesity Therapy?
Meiliana, A., & Wijaya, A. (2009) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v1i3.99 · Cited by 79
Cooper, S. J. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.009 · Cited by 84
Cannabinoid-1 Receptor Antagonist, Rimonabant, for Management of Obesity and Related Risks
Gadde, K. M., & Allison, D. B. (2006) · Circulation · doi:10.1161/circulationaha.105.596130 · Cited by 85
Bariatric surgery in class I obesity (body mass index 30–35 kg/m2)
ASMBS Clinical Issues Committee (2012) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2012.09.002 · Cited by 79
Stubbs, R. J., Morris, L., Pallister, C., Horgan, G. W., & Lavin, J. (2015) · BMC Public Health · doi:10.1186/s12889-015-2225-0 · Cited by 81
Pharmacologic Therapies for Obesity
Kaplan, L. M. (2010) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2010.01.001 · Cited by 76
Treating the metabolic syndrome
Bianchi, C., Penno, G., Romero, F., Prato, S. D., & Miccoli, R. (2007) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.5.3.491 · Cited by 83
Stubbs, R. J., Pallister, C., Whybrow, S., Avery, A., & Lavin, J. (2011) · Obesity Facts · doi:10.1159/000327249 · Cited by 83
GLP-1 receptor agonists in the treatment of polycystic ovary syndrome
Lamos, E. M., Malek, R., & Davis, S. N. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1292125 · Cited by 76
Obesity Research—Limitations of Methods, Measurements, and Medications
Simons-Morton, D. G. (2006) · JAMA · doi:10.1001/jama.295.7.826 · Cited by 70
Impact of Obesity on Gynecology
Pandey, S., & Bhattacharya, S. (2010) · Women s Health · doi:10.2217/whe.09.77 · Cited by 81
5-HT2C Receptor Agonists and the Control of Appetite
Halford, J. C. G., & Harrold, J. A. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-24716-3_16 · Cited by 69
Review Paper: Current Strategies in the Development of Anti-obesity Drugs and Their Safety Concerns
Elangbam, C. S. (2008) · Veterinary Pathology · doi:10.1354/vp.46-1-10 · Cited by 72
Bupropion for weight reduction
Gadde, K. M., & Xiong, G. L. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.1.17 · Cited by 69
Halford, J. C. G. (2005) · Appetite · doi:10.1016/j.appet.2005.07.010 · Cited by 74
Greenway, F. L., & Caruso, M. K. (2005) · Expert Opinion on Drug Safety · doi:10.1517/14740338.4.6.1083 · Cited by 70
Obesity is a surgical disease: overview of obesity and bariatric surgery
O’Brien, P. E., Dixon, J. B., & Brown, W. A. (2004) · ANZ Journal of Surgery · doi:10.1111/j.1445-2197.2004.03014.x · Cited by 62
Serotonergic Anti-Obesity Agents
Halford, J. C. G., Boyland, E. J., Lawton, C. L., Blundell, J. E., & Harrold, J. A. (2011) · Drugs · doi:10.2165/11596680-000000000-00000 · Cited by 62
Natural constituents from Cortex Mori Radicis as new pancreatic lipase inhibitors
Hou, X.-D., Ge, G., Weng, Z.-M., Dai, Z., Leng, Y.-H., Ding, L., Jin, L., Yu, Y., Cao, Y., & Hou, J. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.07.011 · Cited by 62
on behalf of the Dutch Bariatric Surgery Group, & Mathus-Vliegen, E. M. H. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803404 · Cited by 61
Di Prospero, N. A., Yee, J., Frustaci, M. E., Samtani, M. N., Alba, M., & Fleck, P. (2021) · Clinical Obesity · doi:10.1111/cob.12433 · Cited by 60
“mediate weight loss are characterized by variable efficacy in addition to clinically significant gastrointestinal (GI), psychiatric and cardiovascular side effects.(18-24) These shortcomings reinforce the need for novel weight-management therapies that are both effective and well tolerated.”
BackgroundThermogenic and metabolic antiobesity drugs: rationale and opportunities
Clapham, J. C., & Arch, J. R. S. (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00608.x · Cited by 60
Recent advancements in drug treatment of obesity
Carter, R. M., Mouralidarane, A., Ray, S., Soeda, J., & Oben, J. A. (2012) · Clinical Medicine · doi:10.7861/clinmedicine.12-5-456 · Cited by 66
Pharmacotherapy of obesity: An update
Cignarella, A., Busetto, L., & Vettor, R. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105649 · Cited by 65
Bennett, J. M., Mehta, S. P., & Rhodes, M. (2007) · Postgraduate Medical Journal · doi:10.1136/pgmj.2006.048868 · Cited by 68
Lifestyle strategies for weight control: experience from the Finnish Diabetes Prevention Study
Lindström, J., Peltonen, M., Tuomilehto, J. O., & for the Finnish Diabetes Prevention Study Group (2005) · Proceedings of The Nutrition Society · doi:10.1079/pns2004412 · Cited by 68
Garcia, S. B., da Costa Barros, L. T., Turatti, A., Martinello, F., Modiano, P., Ribeiro-Silva, A., de Oliveira Vespúcio, M. V., & Uyemura, S. A. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.09.011 · Cited by 57
Paccosi, S., Cresci, B., Pala, L., Rotella, C. M., & Parenti, A. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190124121725 · Cited by 59
Influenza Viruses in Animal Wildlife Populations
Webby, R. J., Webster, R. G., & Richt, J. A. (2007) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-70962-6_4 · Cited by 66
Das, C., Mendez, G., Jagasia, S., & Labbate, L. A. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400306 · Cited by 66
Drugs in the treatment of obesity: sibutramine, orlistat and rimonabant
Rubio, M. Á., Gargallo, M., Millán, A. I. J., & Moreno, B. (2007) · Public Health Nutrition · doi:10.1017/s1368980007000717 · Cited by 59
Promoting Oral Cancer Awareness and Early Detection using a Mass Media Approach
Saleh, A., Yang, Y., Ghani, W. M. N., Abdullah, N., Doss, J. G., Navonil, R., Rahman, Z. A. A., Ismail, S. M., Talib, N. A., Zain, R. B., et al. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.4.1217 · Cited by 51
Polycystic Ovary Syndrome in Adolescents: Current and Future Treatment Options
Mastorakos, G. P., Lambrinoudaki, I. V., & Creatsas, G. K. (2006) · Pediatric Drugs · doi:10.2165/00148581-200608050-00004 · Cited by 58
Metadata
- Authors
- Padwal, R., Li, S. K., & Lau, D. C. W.
- Affiliations
- University of Alberta Hospital (CA)
- University of Calgary (CA)
- Corresponding author
- Padwal, R
- ORCID
- Venue
- International Journal of Obesity
- Published
- 2003-09-16
- Volume
- 27
- Issue
- 12
- Pages
- 1437-1446
- ISSN
- 0307-0565 (ISSN-L)
- 1476-5497
- OpenAlex
- W2135749311
- Cited by
- 348
- References
- 57
- Citations by year
- 2026: 1 · 2025: 11 · 2024: 2 · 2023: 6 · 2022: 3 · 2021: 6 · 2020: 5 · 2019: 8 · 2018: 8 · 2017: 9 · 2016: 8 · 2015: 11 · 2014: 13 · 2013: 21 · 2012: 20
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- International Journal of Obesity (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Keywords
- anti-obesity drugs, orlistat, sibutramine, obesity, overweight, weight loss, long-term efficacy, drug safety, gastrointestinal adverse effects, blood pressure, cardiovascular risk
- MeSH terms
- Orlistat, Cyclobutanes, Humans, Lactones, Obesity, Randomized Controlled Trials as Topic, Anti-Obesity Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.